INDP Stock Analysis: Buy, Sell, or Hold?
INDP - Indaptus Therapeutics, Inc. Common Stock
$3.03
0.09 (3.06%)
▲
5d:
-7.06%
30d:
+40.93%
90d:
+78.24%
HOLD
LOW Confidence
Analysis Updated: Jul 2, 2026 12:00 AM ET
Earnings: Aug 12, 2026
Get Alerted When INDP Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: INDP shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: INDP shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: INDP is currently trading at $3.03, which is considered fair relative to its 30-day fair value range of $1.99 to $3.91.
Technical Outlook: Technically, INDP is in a uptrend. Immediate support is located at $2.81, while resistance sits at $4.60. The stock is showing strong short-term momentum, up 3.1% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $10.00 (+230.0%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, INDP is in a uptrend. Immediate support is located at $2.81, while resistance sits at $4.60. The stock is showing strong short-term momentum, up 3.1% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $10.00 (+230.0%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$1.99 -
$3.91
Company Quality Score
49/100
(HOLD)
Volume Confirmation
MODERATE
Confidence Score
74.7%
All Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: Strong upward momentum (+3.1%)
- BULLISH: Trading 230.0% below Wall St target ($10.00)
- CAUTION: Recommendation downgraded due to -7.1% 5-day decline
Trading Range Analysis
30-Day Trading Range
$1.99 -
$3.91
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$2.81
Resistance Level
$4.60
Current Trend
Uptrend
Technical data as of
Jul 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-0.68
Wall Street Target
$10.00
(+230.0%)
Share & Embed Analysis
Last updated: July 02, 2026 9:39 PM ET
Data refreshes hourly during market hours. Next update: 10:39 PM
Data refreshes hourly during market hours. Next update: 10:39 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is INDP showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
CRSP
Crispr Therapeutics AG |
BUY
28 analysts |
$84 | 63 BUY |
|
IONS
Ionis Pharmaceuticals Inc |
BUY
26 analysts |
$106 | 64 BUY |
|
LEGN
Legend Biotech Corp |
STRONG BUY
22 analysts |
$57 | 51 HOLD |
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
19 analysts |
$276 | 55 HOLD |
|
MRUS
Merus BV |
STRONG BUY
17 analysts |
$97 | 55 HOLD |
